Holmusk is building the largest Real-World Evidence platform, focusing initially on behavioral health. The company aims to transform behavioral health care by utilizing Real-World Evidence, AI-powered analytics, and digital solutions. Holmusk has developed the NeuroBlu Database, which provides comprehensive clinical data for over 30 geographically diverse health systems to study behavioral health conditions. It leverages advanced natural language processing to extract insights from clinical notes and supports stakeholders like researchers, clinicians, and payers to improve treatment, care delivery, and patient outcomes. Holmusk is recognized for its innovative approach in the fields of behavioral health and real-world data analytics.